Skip to content
1st Counsel – Lifestyle
Author:
Chamberlain Communications Group LLC / on behalf of Mitsubishi Tanabe Pharma America
Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi
April 1, 2026
/C O R R E C T I O N — American Academy of Pediatrics/
March 16, 2026
Federal Judge Blocks Immunization Schedule Changes, Stays ACIP Member Appointments
March 16, 2026
Tanabe Pharma America to Highlight Research in ALS at 2026 MDA Clinical and Scientific Conference
March 5, 2026